Loading...

APC anti-mouse Ly-6G Antibody

Pricing & Availability
Clone
1A8 (See other available formats)
Regulatory Status
RUO
Other Names
Lymphocyte antigen 6 complex, locus G
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
1A8_APC_091809
C57BL/6 bone marrow cells stained with 1A8 APC
  • 1A8_APC_091809
    C57BL/6 bone marrow cells stained with 1A8 APC
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
127613 25 µg £61
Check Availability


Need larger quantities of this item?
Request Bulk Quote
127614 100 µg £215
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Lymphocyte antigen 6 complex, locus G (Ly-6G), a 21-25 kD GPI-anchored protein, is expressed on the majority of myeloid cells in bone marrow and peripheral granulocytes.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Ly-6G transfected EL-4J cell line.
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.06 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

While 1A8 recognizes only Ly-6G, clone RB6-8C5 recognizes both Ly-6G and Ly-6C. Clone RB6-8C5 binds with high affinity to mouse Ly-6G molecules and to a lower extent to Ly-6C15. Clone RB6-8C5 impairs the binding of anti-mouse Ly-6G clone 1A815. However, clone RB6-8C5 is able to stain in the presence of anti-mouse Ly-6C clone HK1.416.

Additional reported applications (for the relevant formats) include: immunohistochemistry9 of frozen sections10 and paraffin-embedded sections11, depletion4, 12-14, and spatial biology (IBEX)20,21. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for in vivo studies or highly sensitive assays (Cat. No. 127632, 127649, 127650, 127661 and 127662).

Application References

(PubMed link indicates BioLegend citation)
  1. Fleming TJ, et al. 1993. J. Immunol. 151:2399. (FC)
  2. Daley JM, et al. 2008. J. Leukocyte Biol. 83:1. (FC)
  3. Dietlin TA, et al. 2007. J. Leukocyte Biol. 81:1205. (FC)
  4. Daley J, et al. 2007. J. Leukocyte Biol. doi:10.1189. (Deplete) PubMed
  5. Tadagavadi RK, et al. 2010. J. Immunol. 185:4904. PubMed
  6. Sumagin R, et al. 2010. J. Immunol. 185:7057. PubMed
  7. Guiducci C, et al. 2010. J. Exp Med. 207:2931. PubMed
  8. Fujita M, et al. 2011. Cancer Res. 71:2664. PubMed
  9. Van Leeuwen, et al. 2008. Arterioscler. Thromb. Vasc. Biol. 28:84. (IHC)
  10. Kowanetz M, et al. 2010. P. Natl. Acad. Sci. USA 107:21248. [supplementary data] (IHC)
  11. Esbona K, et al. 2016. Breast Cancer Res. 18:35. (IHC)
  12. Wojtasiak M, et al. 2010. J. Gen. Virol. 91:2158. (FC, Deplete)
  13. Jaeger BN, et al. 2012. J. Exp. Med. 209:565. (Deplete)
  14. Wozniak KL, et al. 2012. BMC Immunol. 13:65 (FC, Deplete)
  15. Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538.
  16. Ng LG, et al. 2011. J Invest. Dermatol. 131:2058. PubMed
  17. Ma C, et al. 2012. J. Leukoc. Biol. 92:1199.
  18. McCartney-Francis, N, et al. 2014. J Leukoc. Biol. 96:917. PubMed
  19. Her Z, et al. 2014. EMBO Mol. Med. 7:24. PubMed
  20. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  21. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Xue F, et al. 2020. Int J Biol Sci. 2.105555556. PubMed
  2. Patras KA, et al. 2019. J Innate Immun. :1. PubMed
  3. Yu‐Han Chang et al. 2017. Immunity. 47(5):943-958 . PubMed
  4. Li A, et al. 2020. Oncol Lett. 1.899305556. PubMed
  5. Cheng C, et al. 2022. Cell Mol Gastroenterol Hepatol. 15:261. PubMed
  6. Peng W, et al. 2022. Cell Mol Life Sci. 79:602. PubMed
  7. Li J, et al. 2022. Elife. 11:. PubMed
  8. Wilson NG, et al. 2023. iScience. 26:105991. PubMed
  9. Aso K, et al. 2023. Nat Commun. 14:984. PubMed
  10. Zhou M, et al. 2023. Biomed Pharmacother. 161:114530. PubMed
  11. Latour YL, et al. 2023. Gut Microbes. 15:2192623. PubMed
  12. Chung JY, et al. 2023. Nat Commun. 14:1794. PubMed
  13. Choi YJ, et al. 2023. Nat Commun. 14:2045. PubMed
  14. Zhu CL, et al. 2023. Int J Biol Sci. 19:1413. PubMed
  15. Seclì L, et al. 2023. J Immunother Cancer. 11:. PubMed
  16. Banka AL, et al. 2023. Nat Commun. 14:2462. PubMed
  17. Taranto D, et al. 2021. Curr Protoc. 1:e147. PubMed
  18. Chen G, et al. 2021. J Mol Cell Cardiol. 159:62. PubMed
  19. Steudler J, et al. 2022. Glia. 70:2045. PubMed
  20. Hong Y, et al. 2022. J Leukoc Biol. 112:425. PubMed
  21. McAlpine CS, et al. 2022. J Exp Med. 219: . PubMed
  22. Jiang H, et al. 2022. Oxid Med Cell Longev. 2022:5064494. PubMed
  23. Nakayama A, et al. 2023. J Exp Med. 220: . PubMed
  24. An HW, et al. 2022. Cell Rep. 41:111878. PubMed
  25. Al-Saafeen BH, et al. 2023. Front Immunol. 13:1017780. PubMed
  26. Sieow JL, et al. 2023. Int J Mol Sci. 24: . PubMed
  27. Yang L, et al. 2023. Acta Pharmacol Sin. :. PubMed
  28. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  29. Parida PK, et al. 2022. Cell Metab. 34:90. PubMed
  30. Friedman D, et al. 2022. J Immunol. 208:1845. PubMed
  31. Cornax I, et al. 2021. Microorganisms. 9:00. PubMed
  32. Stein K, et al. 2016. J Leukoc Biol. 99: 231 - 239. PubMed
  33. Christian D, et al. 2014. Infect Immun . 82:4056. PubMed
  34. Sharma A, et al. 2014. J Infect Dis. . PubMed
  35. Jones NM, et al. 2019. BMC Cancer. 1.127777778. PubMed
  36. Herisson F, et al. 2018. Nat Neurosci. 21:1209. PubMed
  37. Wenzek C, et al. 2022. iScience. 25:105540. PubMed
  38. Ding Z, et al. 2021. Int J Mol Sci. 22:. PubMed
  39. Weiss M, et al. 2015. Proc Natl Acad Sci U S A. 112: 11001-11006. PubMed
  40. Zhang Z, et al. 2020. J Immunol. 204:3400. PubMed
  41. Gonçalves NP, et al. 2017. J Neuroinflammation. 14:115. PubMed
  42. Kobayashi Y, et al. 2018. PLoS One. 13:e0195008. PubMed
  43. Li Y, et al. 2021. Basic Res Cardiol. 116:30. PubMed
  44. Poli V, et al. 2021. iScience. 24:103256. PubMed
  45. Xu ZH, et al. 2021. Mediators Inflamm. 2021:8856326. PubMed
  46. Shu T, et al. 2022. Eur Respir J. Online ahead of print. PubMed
  47. Zhang Q, et al. 2021. Theranostics. 11:8301. PubMed
  48. Han J, et al. 2022. FEBS J. 289:417. PubMed
  49. Shani O, et al. 2020. Cancer Res. 80:5317. PubMed
  50. Cheng G, et al. 2021. iScience. 24:102673. PubMed
  51. Patnode M, et al. 2014. J Exp Med. 211:1281. PubMed
  52. Liao H, et al. 2015. Rheumatology. 54: 1317 - 1326. PubMed
  53. Schiller M, et al. 2021. Immunity. 54(5):1022-1036.e8. PubMed
  54. Thompson ER, et al. 2020. Am J Transplant. . PubMed
  55. Wang X, et al. 2021. Front Cell Dev Biol. 632805:9. PubMed
  56. Uroda T, et al. 2020. Nat Protoc. 15:2107. PubMed
  57. Di Gioia M, et al. 2020. Nat Immunol. 21:42. PubMed
  58. Meng L, et al. 2021. Front Oncol. 11:691705. PubMed
  59. Mathur S, et al. 2021. JCI Insight. 6:. PubMed
  60. Chen F, et al. 2022. Evid Based Complement Alternat Med. 2022:1240242. PubMed
  61. Royzman D, et al. 2022. Front Immunol. 13:1012647. PubMed
  62. Schlegel M, et al. 2018. J Clin Invest. 128:4711. PubMed
  63. Khan IM, et al. 2021. Immunohorizons. 5:703. PubMed
  64. Bourn JR, et al. 2021. Cancer Lett. 503:75. PubMed
  65. Yao ME, et al. 2022. Evid Based Complement Alternat Med. 2022:7784148. PubMed
  66. Pawaria S, et al. 2020. Arthritis Rheumatol. 72:359. PubMed
  67. Lee M, et al. 2014. PLoS One. 9:112666. PubMed
  68. Mooney J, et al. 2015. Sci Rep. 5: 14603. PubMed
  69. Ma Y, et al. 2016. Cardiovasc Res. 110: 51 - 61. PubMed
  70. Karmakar M, et al. 2016. Nat Commun. 7:10555. PubMed
  71. Chu C, et al. 2016. Dis Model Mech. 9: 473-481. PubMed
  72. Liu M, et al. 2020. Cell Rep. 32:107990. PubMed
  73. Koren N, et al. 2021. Cell Host Microbe. 29(2):197-209.e5. PubMed
  74. Parlet CP, et al. 2019. Cell Rep. 27:187. PubMed
  75. Fujita K, et al. 2019. Proc Natl Acad Sci U S A. 116:14714. PubMed
  76. Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed
  77. Fulham MA, et al. 2019. Am J Physiol Cell Physiol. 317:C687. PubMed
  78. Michael BD, et al. 2020. Cell Reports. 32(11):108150. PubMed
  79. Uceda-Castro R, et al. 2022. Cell Rep Med. 3:100821. PubMed
  80. McAlpine CS, et al. 2021. Nature. 595:701. PubMed
  81. Goldman E, et al. 2021. Cells. 10:. PubMed
  82. Kornstädt L, et al. 2021. Front Immunol. 11:607048. PubMed
  83. Pan YC, et al. 2021. Mol Ther Oncolytics. 20:175. PubMed
  84. Cui C, et al. 2021. Cell. 184(12):3163-3177.e21. PubMed
  85. Okubo K, et al. 2021. Cell Reports. 35(7):109142. PubMed
  86. Abdul Pari AA, et al. 2020. Cancer Res. 80:2586. PubMed
  87. Körner A, et al. 2019. Nat Commun. 10:633. PubMed
  88. Doonan J, et al. 2019. Nat Commun. 10:1554. PubMed
  89. Rashidi M, et al. 2019. J Immunol. 203:736. PubMed
  90. Wang W, et al. 2020. Immunity. 51(6):1102-1118.e7.. PubMed
  91. Gottfried-Blackmore A, et al. 2009. Proc Natl Acad Sci U S A. 106:20918. PubMed
  92. Ulrich-Lewis JT, et al. 2022. Front Immunol. 13:861710. PubMed
  93. Horn KJ, et al. 2022. Nat Commun. 13:3321. PubMed
  94. Friedman DJ, et al. 2021. Cancer Immunol Res. 9:952. PubMed
  95. Formaglio P, et al. 2021. Immunity. 54:2724. PubMed
  96. Bao C, et al. 2021. Infect Immun. 89:. PubMed
  97. Guo P, et al. 2021. J Immunol. 207:408. PubMed
  98. Zhu H, et al. 2021. Cell Metabolism. :. PubMed
  99. Tartey S, et al. 2021. Cancer Research. 81(9):2358-2372. PubMed
  100. Zhou Q, et al. 2014. J Immunol. 193:496. PubMed
  101. Cheng Y, et al. 2020. PLoS Pathog. 16:e1008569. PubMed
  102. Körner A, et al. 2019. Proc Natl Acad Sci U S A. 116:20623. PubMed
  103. Kulkarni U, et al. 2019. Mucosal Immunol. 12:545. PubMed
  104. Wang SS et al. 2018. Cell chemical biology. 25(12):1519-1532 . PubMed
  105. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  106. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  107. Yong L, et al. 2022. Nat Commun. 13:4255. PubMed
  108. , et al. 2021. Eur J Immunol. 51:2708. PubMed
  109. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  110. Wang D, et al. 2021. Nat Commun. 12:2674. PubMed
  111. Price P, et al. 2015. J Immunol. 194:1164. PubMed
  112. Albarrán-Juárez J, et al. 2016. Atherosclerosis. 251:445-53. PubMed
  113. Guldner IH, et al. 2020. Cell. 183(5):1234-1248.e25. PubMed
  114. Fraccarollo D, et al. 2021. eLife. 0.416666666666667. PubMed
  115. Li H, et al. 2019. Front Immunol. 2.205555556. PubMed
  116. Endoh M, et al. 2020. Cell Reports. 30(6):1823-1834. PubMed
  117. Cho K, et al. 2021. iScience. 24:103117. PubMed
  118. Gurusamy M, et al. 2021. Nat Commun. 12:6798. PubMed
  119. Shan C, et al. 2021. Front Immunol. 12:766401. PubMed
  120. Machácek T, et al. 2022. PLoS Pathog. 18:e1010302. PubMed
  121. Xiao Y, et al. 2022. Dis Markers. 2022:1380560. PubMed
  122. Bolkhovitina EL, et al. 2022. Int J Mol Sci. 23: . PubMed
  123. Monteran L, et al. 2022. Nat Commun. 13:5797. PubMed
  124. Steichen A, et al. 2015. PLoS One. 10:123573. PubMed
  125. Cohen M, et al. 2014. EMBO J. 33:2906. PubMed
  126. Liu Z, et al. 2020. Cell. 178(6):1509-1525.e19.. PubMed
  127. Choi EW, et al. 2020. Sci Rep. 10:12001. PubMed
  128. Denny JE, et al. 2019. Sci Rep. 2.786111111. PubMed
  129. Janela B, et al. 2019. Immunity. 50:1069. PubMed
  130. Smith CA, et al. 2019. JCI Insight. 4. PubMed
  131. Toth K, et al. 2022. PLoS Biol. 20:e3001526. PubMed
  132. Rashid MH, et al. 2021. Oncol Rep. 45:1171. PubMed
  133. Zhao D, et al. 2020. Cancer Discov. 10:1374. PubMed
  134. Patankar Y, et al. 2015. Am J Physiol Lung Cell Mol Physiol. 309: L902 - L913. PubMed
  135. Ioannidis L, et al. 2016. J Immunol. 196: 1227 - 1238. PubMed
  136. Wang SS, et al. 2021. Cell Chemical Biology. 28(5):699-710.e5. PubMed
  137. Peñaloza HF, et al. 2018. Biochem Biophys Rep. 13:12. PubMed
  138. Hsu BE et al. 2019. Cell Rep. 27(13):3902-3915 . PubMed
  139. Quenum Zangbede FO, et al. 2018. J Neurosci. 38:6737. PubMed
  140. Wuggenig P, et al. 2020. Commun Biol. 3:130. PubMed
  141. Namiguchi K, et al. 2022. Front Cardiovasc Med. 8:761591. PubMed
  142. Ali S, et al. 2021. PLoS One. 16:e0246646. PubMed
  143. Li YT, et al. 2019. Elife. 8:e47642. PubMed
  144. Bitschar K, et al. 2019. Nat Commun. 10:2730. PubMed
  145. Wingrove E et al. 2019. Cell reports. 27(4):1277-1292 . PubMed
  146. Vasamsetti SB, et al. 2018. Immunity. 49:93. PubMed
  147. Ohno-Urabe S, et al. 2018. J Am Heart Assoc. 7:e007389. PubMed
  148. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
  149. Qadir AS, et al. 2021. iScience. 24:103348. PubMed
  150. Song J, et al. 2021. Am J Physiol Heart Circ Physiol. 320:H323. PubMed
  151. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
  152. Resende M, et al. 2019. J Immunol. 203:2451. PubMed
  153. Salvagno C, et al. 2019. Nat Cell Biol. 1.229861111. PubMed
  154. Cá B, et al. 2019. Front Microbiol. 1.876388889. PubMed
  155. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  156. Chua Y, et al. 2016. J Immunol. 197: 3771 - 3781. PubMed
  157. Ulrich V, et al. 2016. EMBO Mol Med. 8: 643 - 653. PubMed
  158. Grayczyk JP et al. 2017. Cell host & microbe. 22(5):678-687 . PubMed
  159. Georgiadou A, et al. 2022. Elife. 11:. PubMed
  160. Kwon MY, et al. 2021. J Leukoc Biol. 110:711. PubMed
  161. Skokowa J, et al. 2022. Nat Commun. 13:2948. PubMed
  162. Lin T, et al. 2021. PLoS Pathog. 17:e1009557. PubMed
  163. Kamei A, et al. 2012. J Infect Dis. 207:39. PubMed
  164. Gardner P, et al. 2015. Am J Pathol. 185:1324. PubMed
  165. Kuo P, et al. 2016. J Am Heart Assoc. 5: 002610. PubMed
  166. Knuplez E, et al. 2021. British Journal of Pharmacology. 178(5):1234-1248. PubMed
  167. Matsumoto M, et al. 2021. Cell Host Microbe. 29(6):930-940.e4. PubMed
  168. Di Pilato M, et al. 2021. Cell. 184(17):4512-4530.e22. PubMed
  169. Molgora M, et al. 2020. Cell. 182:886. PubMed
  170. Zegarra‐Ruiz DF et al. 2018. Cell host & microbe. 25(1):113-127 . PubMed
  171. Chen L, et al. 2021. Theranostics. 11:6668. PubMed
  172. Katzmarski N, et al. 2021. Nat Immunol. 22:1382. PubMed
  173. Shi J, et al. 2022. Front Pharmacol. 12:818326. PubMed
  174. Gautam S, et al. 2020. Am J Physiol Lung Cell Mol Physiol. 319:L661. PubMed
  175. Siolas D, et al. 2021. Cell Reports. 36:109578. PubMed
  176. Wang M, et al. 2021. iScience. 24(7):102766. PubMed
  177. Aryal B, et al. 2016. Nat Commun. 7:12313. PubMed
  178. Heuslein J, et al. 2016. Sci Rep. 6: 27029. PubMed
  179. Zhao Z, et al. 2019. J Immunol Res. 2019:9561350. PubMed
  180. Asahara M, et al. 2022. PLoS One. 17:e0276135. PubMed
  181. Zhang XL, et al. 2022. J Am Heart Assoc. 11:e023800. PubMed
  182. Andreou T, et al. 2021. J Immunother Cancer. 9:. PubMed
  183. Lee GR, et al. 2021. JCI Insight. 6:. PubMed
  184. Cardoso M, et al. 2015. Infect Immun . 83: 3534-3544. PubMed
  185. Jaeger N, et al. 2020. Cell Rep. 33:108331. PubMed
  186. Zhang J et al. 2019. Cell Rep. 27(9):2679-2689 . PubMed
  187. Liu Z, et al. 2020. STAR Protoc. 1:100029. PubMed
  188. Oertli M, et al. 2011. J Immunol. 187:3578. PubMed
  189. Phadke MS, et al. 2021. Cancer Immunol Res. 9:554. PubMed
  190. Weng JH, et al. 2021. Nat Metab. 3:513. PubMed
  191. Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed
  192. Young K, et al. 2021. Cell Stem Cell. . PubMed
  193. Cardoso F, et al. 2015. PLoS One. 10: 0131904. PubMed
  194. Devi S, et al. 2013. J Exp Med. 210:2321. PubMed
  195. Ershaid N, et al. 2019. Nat Commun. 10:4375. PubMed
  196. Yáñez A et al. 2017. Immunity. 47(5):890-902 . PubMed
  197. Tong Y, et al. 2018. EBioMedicine. 39:132. PubMed
  198. Xu Z, et al. 2022. Cell Death Dis. 13:502. PubMed
  199. Wang S, et al. 2022. Blood. 140:171. PubMed
  200. Liao YC, et al. 2021. Front Immunol. 12:743030. PubMed
RRID
AB_1877163 (BioLegend Cat. No. 127613)
AB_2227348 (BioLegend Cat. No. 127614)

Antigen Details

Structure
A 21-35 kD GPI-anchorded membrane protein
Distribution

Expressed on the majority of myeloid cells in bone marrow and peripheral granulocytes. The monoclonal antibody RB6-8C5 recognizes both Ly-6G and Ly-6C.

Cell Type
Granulocytes, Macrophages, Monocytes
Biology Area
Immunology, Innate Immunity
Antigen References

Fleming TJ, et al. 1993. J. Immunol. 151:2399.

Gene ID
546644 View all products for this Gene ID
UniProt
View information about Ly-6G on UniProt.org

Other Formats

View All Ly-6G Reagents Request Custom Conjugation
Description Clone Applications
Alexa Fluor® 594 anti-mouse Ly-6G 1A8 IHC-F,SB
Purified anti-mouse Ly-6G 1A8 FC,IHC-F,IHC-P,SB
Biotin anti-mouse Ly-6G 1A8 FC,IHC
FITC anti-mouse Ly-6G 1A8 FC
PE anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 647 anti-mouse Ly-6G 1A8 FC,IHC-F,SB
Pacific Blue™ anti-mouse Ly-6G 1A8 FC
APC anti-mouse Ly-6G 1A8 FC
PerCP/Cyanine5.5 anti-mouse Ly-6G 1A8 FC
PE/Cyanine7 anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 700 anti-mouse Ly-6G 1A8 FC,IHC
APC/Cyanine7 anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 488 anti-mouse Ly-6G 1A8 FC,IHC-F,SB
Brilliant Violet 421™ anti-mouse Ly-6G 1A8 FC,IHC-F
Brilliant Violet 570™ anti-mouse Ly-6G 1A8 FC
Ultra-LEAF™ Purified anti-mouse Ly-6G 1A8 FC,Depletion,IHC
Brilliant Violet 510™ anti-mouse Ly-6G 1A8 FC
Purified anti-mouse Ly-6G (Maxpar® Ready) 1A8 FC,CyTOF®,WB
Brilliant Violet 650™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 711™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 605™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 785™ anti-mouse Ly-6G 1A8 FC
PE/Dazzle™ 594 anti-mouse Ly-6G 1A8 FC
APC/Fire™ 750 anti-mouse Ly-6G 1A8 FC
PerCP anti-mouse Ly-6G 1A8 FC
TotalSeq™-A0015 anti-mouse Ly-6G 1A8 PG
TotalSeq™-C0015 anti-mouse Ly-6G 1A8 PG
TotalSeq™-B0015 anti-mouse Ly-6G 1A8 PG
Spark Blue™ 550 anti-mouse Ly-6G 1A8 FC
Spark NIR™ 685 anti-mouse Ly-6G 1A8 FC
Spark YG™ 593 anti-mouse Ly-6G 1A8 FC
APC/Fire™ 810 anti-mouse Ly-6G Antibody 1A8 FC
PE/Cyanine5 anti-mouse Ly-6G 1A8 FC
PE/Fire™ 810 anti-mouse Ly-6G Antibody 1A8 FC
Spark UV™ 387 anti-mouse Ly-6G 1A8 FC
PE/Fire™ 640 anti-mouse Ly-6G 1A8 FC
Spark YG™ 570 anti-mouse Ly-6G 1A8 IHC-F,FC
Go To Top Version: 3    Revision Date: 01/06/2017

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account